Phio Pharmaceuticals And 2 Other Stocks Under $2 Insiders Are Buying

6/12/24 7:07:08 AM ET

Diversified Commercial Services

Consumer Discretionary

Biotechnology: Pharmaceutical Preparations

Health Care

Get the next $FPAY alert in real time by email

The Dow Jones index closed lower by more than 100 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company’s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga’s insider transactions platform.

CarParts.com

The Trade: CarParts.com, Inc. (NASDAQ:PRTS) Director Jim Barnes bought a total of 94,000 shares at an average price of $1.10. To acquire these shares, it cost around $103,400.
What's Happening: On May 7, CarParts.com posted downbeat quarterly results.
What CarParts.com Does: CarParts.com Inc is an online provider of automotive aftermarket parts and repair information.

Phio Pharmaceuticals

The Trade: Phio Pharmaceuticals Corp. (NASDAQ:PHIO) President and CEO Robert J Bitterman acquired a total of 1,000 shares at an average price of $0.74. To acquire these shares, it cost around $740.
What's Happening: On May 17, Phio Pharmaceuticals files for mixed shelf of upto $100 million.
What Phio Pharmaceuticals Does: Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells.

FlexShopper

The Trade: FlexShopper, Inc. (NASDAQ:FPAY) Director Howard Dvorkin acquired a total of 90,921 shares at an average price of $1.13. The insider spent around $102,446 to buy those shares.
What's Happening: On May 13, FlexShopper posted upbeat quarterly sales.
What FlexShopper Does: FlexShopper Inc is a financial technology company engaged in providing certain types of durable goods to consumers on a lease-to-own basis and providing lease-to-own (LTO) terms to consumers of third-party retailers and e-tailers.

Check This Out: Top 4 Health Care Stocks That May Keep You Up At Night This Month

Get the next $FPAY alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$FPAY
$PHIO
$PRTS

Company	Date	Price Target	Rating	Analyst
CarParts.com Inc. $PRTS	3/4/2022	$18.00	Buy	Lake Street
CarParts.com Inc. $PRTS	12/28/2021	$30.00 → $18.00	Buy	Roth Capital
CarParts.com Inc. $PRTS	8/6/2021	$18.00 → $21.00	Outperform	RBC Capital

More analyst ratings

$FPAY
$PHIO
$PRTS
Financials

Live finance-specific insights

FlexShopper, Inc. Reports Record 2024 Third-Quarter Financial Results
Strategic transformation produced record quarterly total revenue of $38.6 million, with earnings increasing to $0.05 per diluted share for the third quarter of 2024 Adjusted EBITDA increased 45% year-over-year to a quarterly record of $12.2 million BOCA RATON, Fla., Nov. 14, 2024 (GLOBE NEWSWIRE) -- FlexShopper, Inc. (NASDAQ:FPAY) ("FlexShopper"), a leading national online lease-to-own ("LTO") retailer and payment solution provider for underserved consumers, today announced its financial results for the quarter ended September 30, 2024. Russ Heiser, Jr, Chief Executive Officer, stated, "2024 is shaping up to be a transformative year for FlexShopper as the strategies we
11/14/24 7:00:00 AM ET
$FPAY
Diversified Commercial Services
Consumer Discretionary
FlexShopper, Inc. Schedules 2024 Third Quarter Financial Results Conference Call
BOCA RATON, Fla., Nov. 11, 2024 (GLOBE NEWSWIRE) -- FlexShopper, Inc. (NASDAQ:FPAY) ("FlexShopper"), a leading national online lease-to-own ("LTO") retailer and payment solution provider for underserved consumers, announced today that it intends to release its financial results for its third quarter ended September 30, 2024, after the market closes on Wednesday, November 13, 2024. The Company intends to hold a conference call to discuss those results the next day, November 14, at 8:30 a.m. Eastern Time. Conference Call and Webcast Details Conference Call Information:Date: November 14, 2024Time: 8:30 a.m. Eastern TimeToll Free Dial In: (877) 407-2988International Dial In: (201) 389-0923Co
11/11/24 4:15:58 PM ET
$FPAY
Diversified Commercial Services
Consumer Discretionary
CarParts.com Reports Third Quarter 2024 Results
TORRANCE, Calif., Oct. 29, 2024 /PRNewswire/ -- CarParts.com, Inc. (NASDAQ:PRTS), a leading eCommerce provider of automotive parts and accessories, and a premier destination for vehicle repair and maintenance needs, is reporting results for the third quarter ended September 28, 2024. Third Quarter 2024 Summary vs. Year-Ago Quarter Net sales decreased to $144.8 million, down 13% from the year-ago quarter.Gross profit of $51.0 million vs. $54.8 million.Gross margin of 35.2%, up from 32.9% from the year-ago quarter.Net loss was ($10.0) million, or ($0.17) per share, compared to
10/29/24 4:01:00 PM ET
$PRTS
Auto & Home Supply Stores
Consumer Discretionary

$FPAY
$PHIO
$PRTS
Leadership Updates

Live Leadership Updates

Phio Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update
Marlborough, Massachusetts--(Newsfile Corp. - August 14, 2024) - Phio Pharmaceuticals Corp. (NASDAQ:PHIO), a clinical stage biotechnology company whose proprietary INTASYL™ siRNA gene silencing technology is designed to make immune cells more effective in killing tumor cells, today reported its financial results for the quarter ended June 30, 2024 and provided a business update.Recent Corporate UpdatesThe Phase 1b clinical trial for our lead product candidate, PH-762, received a positive safety recommendation from the Safety Monitoring Committee (SMC). There were no dose-limiting toxicities, or clinically relevant treatment-emergent adverse events in the initial cohort receiving intratumora
8/14/24 5:00:00 PM ET
$PHIO
Biotechnology: Pharmaceutical Preparations
Health Care
Phio Pharmaceuticals Announces New Chief Financial Officer
Marlborough, Massachusetts--(Newsfile Corp. - August 1, 2024) - Phio Pharmaceuticals Corp. (NASDAQ:PHIO), a clinical stage biotechnology company whose proprietary INTASYL™ siRNA gene silencing technology is designed to make immune cells more effective in killing tumor cells, today announced the appointment of Robert M. Infarinato to the position of vice president and chief financial officer effective August 1, 2024. He will serve in the capacity of Principal Financial Officer including responsibility for accounting, finance, treasury, investor relations and administration. Mr. Infarinato comes to Phio with more than 20 years of financial and accounting leadership experience. He most recen
8/1/24 8:00:00 AM ET
$PHIO
Biotechnology: Pharmaceutical Preparations
Health Care
CarParts.com Announces Appointment of CMO to Support Growth Plans
TORRANCE, Calif., July 18, 2024 /PRNewswire/ -- CarParts.com, Inc. (NASDAQ:PRTS), a technology-driven eCommerce company offering over 1 million high-quality automotive parts and accessories, today announced the appointment of strategic marketing leader Christina Thelin as Chief Marketing Officer (CMO). She will serve as a member of CarParts.com's leadership team, reporting directly to CEO David Meniane. Thelin will oversee product and brand marketing, performance marketing, loyalty marketing, creative, and consumer insights. "As we continue to focus on growth, it is imperative
7/18/24 7:03:00 AM ET
$PRTS
Auto & Home Supply Stores
Consumer Discretionary

CarParts.com Expands Assortment in Automotive Market with SimpleTire Partnership
New Collaboration Adds Over 300 Tire Brands, Broadening Customer Options TORRANCE, Calif., Nov. 20, 2024 /PRNewswire/ -- CarParts.com, Inc. (NASDAQ:PRTS) ("CarParts.com"), a leading eCommerce provider of automotive parts and accessories, is excited to announce its expansion into the tire market through a new partnership with SimpleTire. This launch introduces a robust selection of tire brands to CarParts.com, further enhancing its one-stop-shop experience for vehicle owners across North America. SimpleTire, one of the largest tire distributors in the country, offers a large ca
11/20/24 9:06:00 AM ET
$PRTS
Auto & Home Supply Stores
Consumer Discretionary
Phio Pharmaceuticals Announces Completion of Enrollment in Second Cohort in Phase 1b Dose-Escalating Clinical Study
--Six sites across the U.S. are now engaged in Phase1b study Marlborough, Massachusetts--(Newsfile Corp. - November 19, 2024) - Phio Pharmaceuticals Corp. (NASDAQ:PHIO), a clinical stage biotechnology company exploring new pathways towards a cancer-free future, today announced it has completed the enrollment of its second patient cohort in its PH-762 Phase 1b dose-escalating clinical trial, and added a sixth clinical site in San Diego, CA. Phio recently presented new data from the ongoing clinical trial showing that, of the two patients who have completed treatment in the second dose cohort, one patient with cutaneous squamous cell carcinoma achieved a complete response (100% tumor clearance
11/19/24 7:45:00 AM ET
$PHIO
Biotechnology: Pharmaceutical Preparations
Health Care
Phio Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update
Marlborough, Massachusetts--(Newsfile Corp. - November 14, 2024) - Phio Pharmaceuticals Corp. (NASDAQ:PHIO) is a clinical-stage biotechnology company exploring new pathways towards a cancer-free future by using its INTASYL® siRNA gene silencing technology designed to make the body's immune cells more effective in killing cancer cells today reported its financial results for the quarter ended September 30, 2024 and provided a business update.Recent Corporate UpdatesThe Phase 1b dose escalation clinical trial for our lead product candidate, PH-762, previously received a positive safety recommendation to advance to the next highest dose from the Safety Monitoring Committee (SMC) for the first c
11/14/24 5:47:00 PM ET
$PHIO
Biotechnology: Pharmaceutical Preparations
Health Care